Emmett Cunningham

Dr. Cunningham is an internationally recognized specialist in infectious and inflammatory eye disease with over 350 publications. Dr. Cunningham is a Senior Managing Director at Blackstone Life Sciences, and is an Adjunct Clinical Professor of Ophthalmology at Stanford University School of Medicine and a Research Associate at The Francis I. Proctor Foundation, UCSF School of Medicine. Previously, he was a Managing Director at Clarus Ventures, the Senior Vice President, Medical Strategy at Eyetech Pharmaceuticals, Inc., and Early Clinical Leader at Pfizer. Dr. Cunningham received an MD and MPH in epidemiology and statistics from Johns Hopkins University, and a PhD in neuroscience from the University of California at San Diego.